An update from OncoCyte ( (OCX) ) is now available.
In a significant show of participation, holders of over 64% of voting shares attended a virtual Special Meeting, where they approved both the Amended and Restated Incentive Plan and the potential adjournment of the meeting if quorum requirements weren’t met. This reflects strong shareholder engagement and support for strategic company initiatives.
Learn more about OCX stock on TipRanks’ Stock Analysis page.
